Paula Cobb

Paula Cobb

Chief Operating Officer at
Manifold Biotechnologies, Inc.
53 year
Health Technology
Consumer Services
Health Services

Profile

Paula K.
Cobb
is currently Director at NightstaRx Ltd. and Chief Operating Officer at Manifold Biotechnologies, Inc. Former positions include Independent Non-Executive Director at Nightstar Therapeutics Ltd. from 2018 to 2019, Independent Director at Prothena Corp.
Plc from 2019 to 2025, Senior Vice President-Rare Disease Group at Biogen, Inc. from 2015 to 2016, Chief Operating Officer at Decibel Therapeutics, Inc. in 2019, and Chief Business Officer at Affinia Therapeutics, Inc. from 2020 to 2023.
Education includes undergraduate studies at Amherst College and an MBA from Harvard Business School.

Paula Cobb active positions

CompaniesPositionStart
Director/Board Member -
Chief Operating Officer 2025-11-30

Former positions of Paula Cobb

CompaniesPositionEnd
PROTHENA CORPORATION PLC Director/Board Member 2025-12-30
Corporate Officer/Principal 2022-12-31
DECIBEL THERAPEUTICS, INC. Chief Operating Officer 2019-11-30
NIGHTSTAR THERAPEUTICS PLC Director/Board Member 2019-06-06
BIOGEN INC. Corporate Officer/Principal 2015-12-31
See the detail of Paula Cobb's experience

Training of Paula Cobb

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology